Lakefront Biotherapeutics LKFT
$33.31 −$0.08 (-0.24%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $33.31 0.00%
Open$33.61
Prev close$33.39
Day range$33.25 – $33.85
Volume162.5K
Market cap$2.18B
P/E (TTM)2.5
Dividend yield–
Earnings
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 11 Nov 2026 | None | – | -0.21% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2025/FY
By region
Fundamentals
Latest reported quarter: Q3, ended Sep 2026 · reported in EUR
Revenue€7.58M-89.4% YoY
Operating profit-€41.17M+1.2% YoY
Net profit-€2.67M+98.7% YoY
Diluted EPS-€0.04+98.7% YoY
Free cash flow-€35.45M+45.8% YoY
Operating cash flow-€35.30M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin98.1%
Operating margin65.8%
Net margin85.9%
Return on equity28.0%
Return on assets23.4%
Return on invested capital28.0%
Current ratio46.52
Liabilities / assets1.9%
Cash & investments€2.18B
Total debt€1.83M
Net cash (debt)€2.18B
No comments yet — be the first to weigh in on LKFT.
Sign in to join the discussion.